Clontarf Energy — Interim Statement for period ended 30 June 2026

Clontarf posts another loss and remains years from commercial lithium production.

What the company is saying

Clontarf Energy presents its unaudited financial results for the six months ended 30 June 2026, highlighting a £256,000 loss before tax and administrative expenses of £169,000. The company frames its core narrative around advancing Bolivian lithium interests, specifically through Direct Lithium Extraction and a 50:50 joint venture with NEXT-ChemX. Management emphasizes ongoing engagement with Yacimientos de Litio Bolivianos (YLB) and the aim to secure bulk brine samples for pilot testing in India, but admits that formal agreements and permitting are still pending. The announcement stresses the potential advantages of NEXT-ChemX’s iTDE technology, but repeatedly qualifies these as subject to technical demonstration and commercial-scale verification. The company also references ongoing reforms in Bolivia’s investment framework and the recent appointment of Guillermo Trigo Nagel as interim Executive President of YLB, suggesting a more favorable environment for foreign participation. Clontarf continues to mention its Ghanaian oil and gas interests and states an intention to minimize shareholder dilution through partnerships and project finance, but provides no evidence of new deals or funding. The tone is measured, with forward-looking statements dominating and no claims of imminent operational breakthroughs.

What the data suggests

The disclosed numbers show Clontarf remains a pre-revenue, capital-constrained company, with a £256,000 loss before tax and an £87,000 impairment on exploration and evaluation assets for the half-year. Administrative expenses totaled £169,000, and cash and cash equivalents fell to £248,000 as of 30 June 2026. Total assets stand at £1,396,000, offset by £1,362,000 in liabilities, leaving net liabilities of £34,000 and total equity of just £34,000. The investment in joint venture is unchanged at £888,000, and intangible assets have declined to £260,000. The company’s share capital is £6,509,000, with a share premium of £13,517,000 and a retained deficit of £20,537,000. There is no revenue, no dividend, and no evidence of operational progress beyond continued discussions and aspirations. No production, resource estimate, or pilot-scale results are reported. The financial trajectory is negative, with cash burn continuing and no new funding or offtake agreements disclosed. All project milestones remain contingent on future technical, regulatory, and financial success.

Analysis

The announcement is dominated by forward-looking statements regarding the development of lithium assets in Bolivia, with repeated references to ongoing engagement, intentions to secure bulk samples, and aspirations for commercial-scale DLE facilities. However, there is no evidence of realised operational milestones: no production, resource estimate, or pilot results are disclosed. The only realised figures are financial (loss before tax, impairment, cash), which reflect a pre-revenue, capital-constrained position. The language around partnerships, project finance, and minimising dilution is aspirational, with no signed agreements or concrete funding commitments reported. The capital intensity of the proposed lithium projects is high, but all benefits are long-dated and contingent on multiple uncertain steps (technical, regulatory, financial). The tone is measured, but the gap between narrative and evidence is material, as all substantive project claims remain unproven.

Risk flags

• ●Clontarf’s financial position is precarious, with only £248,000 in cash and net liabilities of £34,000, leaving little room for error or delays. Without new funding or partnerships, the company faces a risk of running out of cash before reaching any operational milestone.
• ●There is no evidence of binding agreements with YLB or other Bolivian authorities, making the timeline for accessing bulk brine samples and advancing pilot testing highly uncertain. Regulatory and permitting delays could stall the project indefinitely.
• ●The entire business plan hinges on the successful technical demonstration and commercial scalability of NEXT-ChemX’s iTDE technology, which remains unproven at scale. If the technology fails to deliver as hoped, the company’s primary asset could be rendered non-viable.
• ●All forward-looking statements about minimising dilution, securing project finance, or attracting offtake partners are aspirational, with no concrete deals or funding in place. This exposes shareholders to significant dilution risk if new equity must be raised under duress.
• ●The company’s Ghanaian oil and gas interests are mentioned but lack any operational progress, agreements, or funding, suggesting these assets are unlikely to generate value in the near term.

Bottom line

Clontarf’s interim results confirm a continued loss-making, pre-revenue position with minimal cash and no operational breakthroughs. The company’s narrative is dominated by aspirations to develop Bolivian lithium assets using unproven extraction technology, but all key milestones—formal agreements, pilot results, permitting, and financing—remain outstanding. The financials show a shrinking asset base, mounting deficit, and no new funding, with net liabilities now at £34,000. Without a near-term catalyst or binding agreements, the risk of further dilution or insolvency is high. Investors should treat all forward-looking statements as contingent on multiple uncertain steps, with commercial production likely years away. The single most important takeaway is that Clontarf remains a high-risk, early-stage play with no imminent path to value realisation.

Announcement summary

(AIM: CLON) Clontarf Energy plc released its unaudited interim financial results for the six months ended 30 June 2026. The company reported administrative expenses of £169,000, an impairment of exploration and evaluation assets of £87,000, and a loss before taxation of £256,000 for the period. The comprehensive income for the period was a loss of £256,000, with a basic and diluted loss per share of (0.003p). As of 30 June 2026, total assets stood at £1,396,000, with non-current assets of £1,148,000 and current assets of £248,000. Total liabilities were £1,362,000, resulting in net liabilities of £34,000 and total equity of £34,000. The company had called-up share capital of £6,509,000 and a share premium of £13,517,000, with a retained deficit of £20,537,000. The weighted average number of ordinary shares in issue during the period was 8,193,326,117. Exploration and evaluation assets at period end were valued at £260,000. An impairment charge of £86,805 was recorded in the current period relating to the Tano 2A Block in Ghana, following a 20% write-down of historic expenditure due to the lack of ratification of the Petroleum Agreement by the Ghanaian government. The company continues to focus on advancing its lithium interests in Bolivia, particularly through Direct Lithium Extraction (DLE) technology in partnership with NEXT-ChemX via a 50:50 joint venture. Clontarf is also engaged with Yacimientos de Litio Bolivianos (YLB) to secure bulk brine samples for pilot-scale testing in India. The company maintains its oil and gas interest in Ghana and is evaluating new opportunities in lithium, critical minerals, and oil and gas projects. James Finn is the Interim Chairman as of 14 September 2026. No dividend is proposed for the period.

Disagree with this article?